FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Actavis BuPROPion Hydrochloride Extended-Release Recall

BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle…

Actavis Inc · Parsippany, NJ

Risk level
Class III
Reported by FDA
Feb 5, 2014
Recall ID
D-1043-2014
Check your lot numberHow we source this data

Summary

Actavis recalled BuPROPion Hydrochloride Extended-Release starting Nov 15, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1043-2014 on Feb 5, 2014. Reason: Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months. Status: Terminated.

Why it was recalled

Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months.

Product description

BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle(NDC 0591-3331-30), b) 90 count bottle (NDC 0591-3331-19), c) 500 count bottle (NDC 0591-3331-05), Manufactactred By: Watson Laboratories, Inc. Corona, CA 92880

Lot numbers, UPCs & expiration codes

Lots: 524099M, 524100A, 521687A

Where it was sold

Nationwide and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1043-2014
Classification
Class III
Status
Terminated
Recall initiated
Nov 15, 2013
FDA report date
Feb 5, 2014
Quantity
139,944 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Actavis Inc

Original FDA data

Every field from FDA enforcement report D-1043-2014, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
66961
Address
400 Interpace Pkwy
Code information
Lots: 524099M, 524100A, 521687A
Postal code
07054-1120
Report date
Feb 5, 2014
Product type
Drugs
Recall number
D-1043-2014
Classification
Class III
Recalling firm
Actavis Inc
Product quantity
139,944 bottles
Termination date
Jun 16, 2015
Reason for recall
Failed Dissolution Specifications: Failed stability testing for dissolution test at 18 months.
Voluntary / mandated
Voluntary: Firm initiated
Product description
BuPROPion Hydrochloride Extended-Release Tablet (XL) 150mg, Rx only, a) 30 count bottle(NDC 0591-3331-30), b) 90 count bottle (NDC 0591-3331-19), c) 500 count bottle (NDC 0591-3331-05), Manufactactred By: Watson Laboratories, Inc. Corona, CA 92880
Distribution pattern
Nationwide and Puerto Rico
Recall initiation date
Nov 15, 2013
Initial firm notification
Letter
Center classification date
Jan 29, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1043-2014, published Feb 5, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls